Bay Street News, September, 2024

28-week data show ESK-001 was generally well tolerated and most patients treated with the top dose of 40 mg twice […]

EDMONTON, Alberta, Sept. 27, 2024 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) will release its third quarter results before […]

Following successful POC project completion, the parties will develop and commercialize AI tele-operations solutions for heavy machinery to improve safety […]

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTIONTO U.S. WIRE SERVICES TORONTO, Sept. 27, 2024 (GLOBE NEWSWIRE) —  Partners […]

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or […]

GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a […]

SINGAPORE, Sept. 27, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth […]

Announces completion of enrollment in its oral allergen challenge study for the development of its late-stage pipeline program, Anaphylm™ (epinephrine) […]

KUALA LUMPUR, Malaysia, Sept. 27, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global,” “VCIG,” or […]

NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical […]